← Back to Search

High volume combined aerobic/resistance exercise for Diabetes (DEAL Trial)

Phase < 1
Waitlist Available
Led By Ron Sigal, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

DEAL Trial Summary

The objective of this study is to determine the effects of supervised combined aerobic and resistance training, and the effects of stage-matched written materials delivered by mail or internet, alone or in combination, on glycemic control as reflected in A1C (glycated hemoglobin).

DEAL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The will be A1c at the end of 6 months supervised exercise period.

DEAL Trial Design

6Treatment groups
Active Control
Placebo Group
Group I: High volume combined aerobic/resistance exerciseActive Control1 Intervention
Group II: Low volume combined aerobic/resistance exerciseActive Control1 Intervention
Low volume combined aerobic/resistance exercise
Group III: High volume combined A/R exercise, printouts, pedometersActive Control1 Intervention
High volume combined aerobic/resistance exercise, printouts, pedometers
Group IV: Low volume combined A/R exercise, printouts, pedometersActive Control1 Intervention
Low volume combined aerobic/resistance exercise, printouts, pedometers
Group V: Printed PA information, pedometers and step log groupActive Control1 Intervention
Printed physical activity information, pedometers and step log group
Group VI: ControlPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,128 Total Patients Enrolled
3 Trials studying Diabetes
395 Patients Enrolled for Diabetes
Ron Sigal, MDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
131 Total Patients Enrolled
1 Trials studying Diabetes
131 Patients Enrolled for Diabetes

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025